SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-10-000997
Filing Date
2010-03-30
Accepted
2010-03-30 07:50:11
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K slxcf_10k.htm 10-K 1453767
2 EXHIBIT 31.1 slxcf_ex311.htm EX-31.1 15627
3 EXHIBIT 31.2 slxcf_ex312.htm EX-31.2 15517
4 EXHIBIT 32.1 slxcf_ex321.htm EX-32.1 6323
5 EXHIBIT 32.2 slxcf_ex322.htm EX-32.2 6258
6 IMAGE stellar_auditor.jpg GRAPHIC 27304
7 IMAGE stellar_auditorsig.jpg GRAPHIC 9177
8 IMAGE deloitte_sig.jpg GRAPHIC 10906
9 IMAGE deloitte.jpg GRAPHIC 6831
10 copy.jpg GRAPHIC 6140
  Complete submission text file 0001354488-10-000997.txt   1582850
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31198 | Film No.: 10712177
SIC: 2834 Pharmaceutical Preparations